Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsCytomegalovirus InfectionsRoseolovirus InfectionsTransplantation, AutologousAspergillosisHistocompatibility TestingStem CellsTissue DonorsBone Marrow TransplantationTreatment OutcomeCytomegalovirusFetal BloodTransplantation ChimeraRetrospective StudiesHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationGraft SurvivalBusulfanRecurrenceGraft vs Leukemia EffectImmunosuppressive AgentsLeukemiaRemission InductionVidarabineMyeloablative AgonistsHistocompatibilityGraft vs Tumor EffectWhole-Body IrradiationImmunocompromised HostTransplantationTime FactorsT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteLymphocyte DepletionMultiple MyelomaEmbryonic Stem CellsAntigens, CD34Blood DonorsCombined Modality TherapySpinal CordSalvage TherapyHematopoietic Stem Cell MobilizationPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsSurvival AnalysisVirus ActivationSiblingsAdult Stem CellsSurvival RateChimerismGraft RejectionMycosesCell DifferentiationAcute DiseaseAnemia, AplasticLymphocyte TransfusionMyelodysplastic SyndromesLiving DonorsCells, CulturedHepatic Veno-Occlusive DiseaseHematologic DiseasesImmunosuppressionLeukocyte TransfusionMinor Histocompatibility AntigensHLA AntigensFlow CytometryAntilymphocyte SerumPluripotent Stem CellsTransplantation ImmunologyHerpesvirus 6, HumanBone Marrow CellsCyclophosphamideDisease-Free SurvivalBlood Transfusion, AutologousGanciclovirAntineoplastic Combined Chemotherapy ProtocolsKidney TransplantationFollow-Up StudiesMelphalanNeoplasm, ResidualSpinal Cord InjuriesFatal OutcomeMice, Inbred C57BLCell SeparationMesenchymal Stem Cell TransplantationCyclosporineAntiviral AgentsLymphoproliferative DisordersLymphocyte Culture Test, MixedIsoantigensInduced Pluripotent Stem CellsMesenchymal Stromal CellsLeukemia, Myeloid